Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017

To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to seroty...

Full description

Bibliographic Details

Published in:	Emerging Infectious Diseases
Main Authors:	Satoshi Nakano, Takao Fujisawa, Yutaka Ito, Bin Chang, Yasufumi Matsumura, Masaki Yamamoto, Shigeru Suga, Makoto Ohnishi, Miki Nagao
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2020-11-01
Subjects:	Streptococcus pneumoniae 12F ST4846 13-valent pneumococcal conjugate vaccine PCV13 Japan
Online Access:	https://wwwnc.cdc.gov/eid/article/26/11/20-0087_article